A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor
Clinical trial NCT06109311 · COMPLETED
Trial details
- NCT number
- NCT06109311
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-10
- Primary completion
- 2025-09-15
- Enrollment
- 546
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.